SPINE
Tranexamic acid reduces blood loss and required transfusions due to spinal surgery
Eur Spine J. 2013 Sep;22(9):1950-7Six randomized control trials were included in this meta-analysis to evaluate the efficiency of intravenous tranexamic acid (TXA) in reducing blood loss during spinal surgery. The results of this meta-analysis suggested that TXA successfully reduced the amount of blood lost preoperatively and the incidence of patients requiring transfusions. It should be noted that the number of studies was small and that two quasi-randomized trials were included.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
